8
Participants
Start Date
August 31, 2004
Primary Completion Date
January 31, 2006
Study Completion Date
January 31, 2006
Nefopam Low dose
Continuous intravenous infusion at 0.5 mg/ml for three hours.
Nefopam High dose
Continuous intravenous infusion at 1.0 mg/ml for three hours.
Department of Anesthesiology, University of Bern, Bern
Laboratoires Biocodex (Montrouge, France)
UNKNOWN
The Cleveland Clinic
OTHER